• Ibrexafungerp and Caspofungin: Efficacy Against Resistant Ca

  2026-04-20

  Wiederhold et al. demonstrate that ibrexafungerp exhibits potent in vitro and in vivo activity against fluconazole-resistant Candida auris, even with delayed therapy initiation. The study provides critical protocol and efficacy data for antifungal agents targeting the β-(1,3)-D-glucan biosynthesis pathway, with practical benchmarks for research on azole-resistant Candida infections.

• Prochlorperazine as a Dopamine D2 Receptor Antagonist in Can

  2026-04-20

  Prochlorperazine’s robust profile as a dopamine D2 receptor antagonist enables precise control in both antiemetic therapy and advanced cancer research. Explore workflow-ready protocol enhancements, troubleshooting strategies, and critical safety insights that empower researchers to achieve reproducible, data-driven results with APExBIO’s validated reagent.

• MLN4924 HCl Salt: Precision NEDD8-Activating Enzyme Inhibiti

  2026-04-19

  MLN4924 HCl salt empowers researchers to dissect neddylation pathway inhibition in real time, enabling high-specificity modulation of cullin-RING ligases and protein degradation in cancer biology research. This guide delivers hands-on workflows, protocol optimizations, and troubleshooting rooted in peer-reviewed data and recent advances in viral immunity.

• Deep Learning Identifies Cardiotoxicity in iPSC-CMs Screenin

  2026-04-18

  This study demonstrates the integration of deep learning with high-content imaging to sensitively detect cardiotoxic effects in induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs). The approach enables early, scalable identification of drug-induced toxicity, improving risk assessment in drug discovery.

• Mitochondrial Membrane Potential: From Mechanism to Translat

  2026-04-17

  This thought-leadership article explores how advances in mitochondrial membrane potential (ΔΨm) analysis, exemplified by the TMRE mitochondrial Membrane Potential Assay Kit, are redefining translational research. By weaving mechanistic insights from recent studies—including sodium-driven NECSO-induced mitochondrial dysfunction—into strategic experimental frameworks, the article guides translational scientists in leveraging high-content ΔΨm assays for apoptosis research, disease modeling, and therapeutic innovation. The piece also critically contrasts competitive assays, addresses workflow challenges, and forecasts the evolving landscape of mitochondrial research.

• Targeting FGFR2 Fusions in ICC via Heteroduplex Oligonucleot

  2026-04-16

  The referenced study introduces a cholesterol-conjugated DNA/RNA heteroduplex oligonucleotide (Cho-HDO) that specifically targets FGFR2-AHCYL1 fusion transcripts in intrahepatic cholangiocarcinoma (ICC). By coupling this approach with asparagine depletion, the study delineates a potent synergistic strategy to restrict tumor growth and overcome bypass resistance mechanisms in FGFR2 fusion-driven ICC.

• Ertugliflozin Cardiovascular Outcomes in Type 2 Diabetes: VE

  2026-04-15

  The VERTIS CV trial rigorously evaluated the cardiovascular safety of ertugliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes and established atherosclerotic cardiovascular disease. Key findings demonstrated noninferiority to placebo for major adverse cardiovascular events, offering important evidence for clinicians and researchers regarding SGLT2 inhibitor use in high-risk diabetic populations.

• Cy5-UTP: Illuminating RNA Structure and Dynamics with Precis

  2026-04-14

  Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) enables single-molecule insights into RNA folding and gene regulation. This in-depth guide uniquely connects advanced fluorescent RNA labeling to mechanistic discoveries in riboswitch biology.

• Phosbind Biotin LC: Practical Guide for Phosphorylation Dete

  2026-04-13

  Phosbind Biotin LC is a phosphate-binding reagent for sensitive, sequence-independent detection of phosphorylated proteins on PVDF membranes, primarily in Western Blot applications. It provides an alternative to phospho-specific antibodies, particularly when antibody availability or sequence specificity is a limitation. This reagent should not be used in aqueous-only protocols or stored as a working solution.

• Doxorubicin Hydrochloride: Optimized Workflows for Cancer an

  2026-04-13

  Doxorubicin hydrochloride (Adriamycin HCl) stands as a gold-standard DNA topoisomerase II inhibitor, supporting advanced cancer chemotherapy research and robust cardiotoxicity modeling. This article delivers actionable experimental workflows, protocol enhancements, and troubleshooting guidance for maximizing data quality using APExBIO’s research-grade Doxorubicin (Adriamycin) HCl.

• Mitoxantrone HCl: DNA Topoisomerase II Inhibitor in Cancer R

  2026-04-12

  Mitoxantrone HCl, a potent DNA topoisomerase II inhibitor, empowers researchers to dissect DNA damage, apoptosis, and resistance mechanisms in cancer and immune cells. APExBIO’s formulation offers robust solubility, reproducibility, and performance, making it indispensable for advanced viability and mechanistic assays.

• EPZ-6438: EZH2 Inhibitor Workflows for Epigenetic Cancer Mod

  2026-04-12

  EPZ-6438 empowers researchers to dissect the PRC2 pathway with nanomolar precision in diverse epigenetic cancer models, including HPV-associated cervical cancer. This article translates breakthrough reference findings into detailed, actionable workflows and troubleshooting strategies for maximal experimental rigor.

• Dacarbazine in Cancer Research: Protocols, Workflows, and Tr

  2026-04-11

  Dacarbazine remains a gold-standard antineoplastic chemotherapy drug for modeling DNA damage in cancer cells, with unique value in melanoma, Hodgkin lymphoma, and sarcoma research workflows. This article translates advanced in vitro methodologies and troubleshooting strategies into practical, reproducible protocols for researchers leveraging APExBIO's Dacarbazine.

• Dabigatran in Coagulation Function Tests: Protocols & Insigh

  2026-04-11

  Dabigatran (Pradaxa) stands out as a direct thrombin inhibitor, delivering unrivaled sensitivity and reproducibility in coagulation function tests. This guide translates recent research into step-by-step protocols, troubleshooting tips, and advanced applications for bench scientists, leveraging APExBIO’s high-purity Dabigatran for robust results.

• Epinastine HCl in Allergy Mechanism and Histamine Receptor R

  2026-04-10

  Epinastine hydrochloride (Epinastine HCl) provides a robust tool for researchers examining histamine H1 receptor antagonism and mechanisms of allergic conjunctivitis in vitro. It is not suitable for in vivo studies or clinical applications, and results must be interpreted within the context of its documented stability and solubility profile.

15617 records 1/1042 page Next 12345 下5页 Last page